Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Raynaud's phenomenon: pathogenesis and management.

Richard Bakst1, Joseph F Merola, Andrew G Franks

  • 1Ronald O. Perelman Department of Dermatology, New York University Medical Center, New York, New York 10016, USA.

Journal of the American Academy of Dermatology
|July 29, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progression from oligoarticular to polyarticular psoriatic arthritis and apremilast as a disease modifier: novel insights from FOREMOST.

Rheumatology (Oxford, England)·2026
Same author

Targeted Therapy, Untargeted Rash: Insights From a GRAPPA Workshop on Immune Shifts in Psoriatic Disease.

The Journal of rheumatology·2026
Same author

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Comorbidity burden across cutaneous lupus subtypes: A large US electronic health record database study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Lichen planus autoimmune comorbidities: A retrospective case control study.

Dermatology online journal·2026
Same author

Durability of response to icotrokinra for high-impact site psoriasis: 1-year ICONIC-TOTAL findings.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Dermatologic conditions associated with HIV among US adults across different racial and ethnic groups: A retrospective cohort study using TriNetX.

Journal of the American Academy of Dermatology·2026
Same journal

Ethical Considerations in Same-Day Surgical Treatment of a High-Risk, Poorly Differentiated Squamous Cell Carcinoma.

Journal of the American Academy of Dermatology·2026
Same journal

The Ethics of the Handshake in Dermatology.

Journal of the American Academy of Dermatology·2026
Same journal

Dermatology images: Hidradenitis suppurativa.

Journal of the American Academy of Dermatology·2026
Same journal

Response to Guo et al., "Response to Huang et al.'s 'Real-world efficacy and safety of tofacitinib on the progression of skin sclerosis in patients with systemic sclerosis: an analysis of national multicenter data from the CRDC.'".

Journal of the American Academy of Dermatology·2026
Same journal

Genomic Predictors of Perineural Invasion in Cutaneous Squamous Cell Carcinoma: Insights from an MD Anderson Cohort.

Journal of the American Academy of Dermatology·2026
See all related articles

Raynaud's phenomenon involves recurrent vasospasm in fingers and toes. Recent research explores its underlying causes and potential targeted therapies, as no definitive cure currently exists.

Area of Science:

  • Dermatology
  • Vascular Medicine

Background:

  • Raynaud's phenomenon is a common condition causing vasospasm in extremities, often triggered by cold or stress.
  • Despite extensive research since 1862, its pathophysiology remains unclear, with no established cure or gold standard treatment.
  • Treatment efficacy varies significantly among patients, hindering predictable outcomes.

Purpose of the Study:

  • To review recent advancements in understanding the pathogenesis of Raynaud's phenomenon.
  • To discuss emerging targeted therapeutics for Raynaud's phenomenon.

Main Methods:

  • Literature review of recent studies on Raynaud's phenomenon.
  • Analysis of current research on pathogenetic mechanisms.
  • Evaluation of novel therapeutic approaches.

Related Experiment Videos

Main Results:

  • Renewed interest in pathogenetic mechanisms has identified potential targets for new treatments.
  • Recent breakthroughs offer promise for more effective and predictable therapeutic strategies.

Conclusions:

  • Further research into the pathophysiology of Raynaud's phenomenon is crucial.
  • Emerging therapeutics show potential for improved patient outcomes.
  • Continued investigation may lead to a definitive cure or gold standard therapy.